Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 554 for “"Lymphoblastic Leukemia"”.
-
CD28 in T cell acute lymphoblastic leukemia
… an increasing role in treatment of pediatric leukemia, the most common cancer in childhood. Especially CAR T cell therapy for B-lineage malignancies has entered clinical routine. However, whereas prognosis for B-ALL has been improved, outcomes of T-ALL still lag behind, in particular when …
-
Targeted therapies for adult acute lymphoblastic leukemia
Η θεραπεία της οξείας λεμφοβλαστικής λευχαιμίας με μονοκλωνικά αντισώματα είναι στοχευμένη/ εξειδικευμένη, με διαφορετικό μηχανισμό δράσης από την χημειοθεραπεία και διαφορετικές παρενέργειες. Ο συνδυασμός των στοχεμένων θεραπειων με την χημειοθεραπεία μειώνει τον κινδυνο υποτροπής της νόσου.
-
ALLRecovery – Mobile App for Acute Lymphoblastic Leukemia Education
Acute lymphoblastic leukemia (ALL) is a cancer of the bone marrow. Lymphoblasts are unable to mature due to errors in signaling leading to an accumulation of non-functioning lymphoblasts. ALL is one of the most common cancers found in children; with an estimated 6590 new cases in the United States …
-
Mechanisms of therapy resistance in acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a highly aggressive pediatric cancer that can affect both B cells and T cells. The advent of new therapies has increased the cure rates for both B-ALL and T-ALL patients. However, some patients still experience relapse with a variable response to the treatment …
-
Characterizing and Targeting Residual Disease in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the most prevalent childhood cancer, with a favorable prognosis in most cases. However, relapse remains a significant challenge for 15-20% of children with ALL, with early response to treatment as a critical predictor. Minimal residual disease (MRD) is defined …
-
Origin of Disease Heterogeneity in BCR-ABL1 Lymphoblastic Leukemia
BCR-ABL1 positive acute lymphoblastic leukemia (ALL) is an aggressive subtype of ALL that commonly appears in adults. Introduction of tyrosine kinase inhibitors into frontline treatments has significantly improved outcomes; however, the disease still frequently relapses and becomes refractory to …
-
Chromatin Architecture Aberrations Contribute and Acute Lymphoblastic Leukemia Relapse
… epigenetic changes that underlie B-cell acute lymphoblastic leukemia relapse. I found recurrent loss of DNA methylation in patient-matched relapse samples that indicate a more stem-like chromatin state. Together, my work investigates the relationship between multiple components of the chromatin …
-
Developing Targeted Therapies for T-cell Acute Lymphoblastic Leukemia
Introduction Acute lymphoblastic leukemia (ALL) is the most common cancer in children, and risk-adapted chemotherapies have dramatically improved the outcomes of this disease. Compared to B-cell ALL, T-cell ALL (T-ALL) is more aggressive and has worse outcomes from chemotherapy. There is a great …
-
Modeling central nervous system involvement in acute lymphoblastic leukemia
… the problematic disease manifestations of acute lymphoblastic leukemia (ALL). Modern prophylactic measures have decreased the rate of CNS involvement in ALL. However, they produce adverse side effects, including cognitive dysfunction, seizures, and growth retardation, which have unique …
-
Stem and progenitor cell involvement in acute lymphoblastic leukemia
… The focus of this thesis is on pre B cell Acute Lymphoblastic Leukemia (ALL), the most common form of cancer in children. We have investigated 2 distinct subtypes of ALL, characterized by the gene fusions ETV6-RUNX1 (found mainly in pediatric ALL, conferring a favorable prognosis) and BCR-ABL1 …
-
Genomic characterization of ETV6/RUNX1-positive acute lymphoblastic leukemia
… fusion gene, present in 25% of childhood acute lymphoblastic leukemia. This fusion gene is important for leukemia development but is not sufficient for leukemia to arise. Hence, the additional genetic changes present in leukemic ETV6/RUNX1-positive cells give important clues regarding the …
-
Genetic Characterization of Pediatric T-cell Acute Lymphoblastic Leukemia
… characterize genetically pediatric T-cell acute lymphoblastic leukemia (T-ALL). Articles I and II focus on molecular characterization of translocations involving T-cell receptor (TCR) loci. These types of aberration are characteristic for T-ALL and have previously proved pivotal in the …
-
Motor functioning in childhood survivors of acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) can cause a multitude of neuropsychological sequelae, or late effects, in children following intensive medical treatment. Late effect research has focused primarily on non-motor related sequelae; however, recent studies have begun to highlight evident impairments …
-
Parental Directiveness in Childhood Survivors of Acute Lymphoblastic Leukemia
… problems. Survivors (7-12 years old) of acute lymphoblastic leukemia (n = 25) and their mothers, and healthy controls (n = 22) and their mothers engaged in 10-minute parent-child interactions. Mothers completed a measure of children's psychosocial adjustment and observations of 10-minute …
-
Exploring cell surface-associated proteolytic proteoforms in acute lymphoblastic leukemia
… treatment option for pediatric B cell acute lymphoblastic leukemia (B-ALL). Although effective, it is also harsh and indiscriminate; often leading to acute side effects or secondary diseases and malignancies that manifest later. There is, therefore, a need to seek out more specific …
-
Genomic aberrations and their evolution in adult acute lymphoblastic leukemia /
… aberrations and their evolution in adult acute lymphoblastic leukemia” has two parts, which are very important in the modern oncohematology. In the first part of the research, we selected adult ALL patients in 2007-2013 year period. In this part we perfomed SNP array analysis and determined the …
-
Bone Marrow Microenvironment regulation of BCL6 in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a hematological malignancy with approximately 6000 newly diagnosed cases every year. Although ALL is the most common malignancy in children, it can occur in patients of all ages. Great strides have been made in the treatment of ALL and remission rates are at …
-
Genetic Mechanisms of Transcriptional Regulation in Childhood Acute Lymphoblastic Leukemia
… of the genetic basis of childhood acute lymphoblastic leukemia (ALL). Recent genome-wide association studies (GWAS) have identified germline genetic variations of ARID5B and, more recently, IGF2BP1 that are associated with susceptibility to ALL. Genome-wide sequencing studies also …
-
Characterization of Transcription Factor-Coactivator Complexes in Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a cancerous hematological disorder originating in B-lymphoid progenitor cells. In 5% of ALL cases, the oncogenic transcription factor E2A-PBX1 is expressed as a result of the chromosomal translocation 1;19. E2A-PBX1 contains the activation domains of E2A and …
Page 1 of 28